Safety and Efficacy of SHURUI Single-Port Serpentine-Arm Robotic Surgery System in Lung Surgery: A Prospective Single-Centre Study
- PMID: 41172271
- PMCID: PMC12597871
- DOI: 10.1093/icvts/ivaf232
Safety and Efficacy of SHURUI Single-Port Serpentine-Arm Robotic Surgery System in Lung Surgery: A Prospective Single-Centre Study
Abstract
Objectives: The integration of robot-assisted thoracic surgery (RATS) and uniportal video-assisted thoracic surgery (VATS) is poised to become a key direction for future advancements. The SHURUI single-port (SP) Robotic Surgery System, China's first domestically developed SP endoscopic system, has shown promise in urological and gynaecological surgeries but lacks thoracic application data. This study evaluates its safety and efficacy in anatomical lung resection.
Methods: A prospective single-centre trial enrolled 15 patients undergoing robotic pulmonary resection. The SHURUI system, featuring serpentine-arm instruments with dual continuum mechanisms, was deployed via a fifth/sixth intercostal incision. Primary endpoints included the non-conversion rate and the incidence of device-related or potentially device-related surgical complications meeting Clavien-Dindo grade 3 or higher criteria; secondary endpoints encompassed operative time, blood loss, pain scores, surgeon satisfaction, the incidence of adverse events, transfusion rates, 30-day readmission rates, 30-day reoperation rates, and 30-day mortality.
Results: All procedures (8 lobectomies, 5 segmentectomies, and 2 sleeve lobectomies) achieved 100% non-conversion, with one case requiring an auxiliary port. Median total operative time, port creation time, docking time, and console time were 174 minutes (117-335), 14 minutes (8-30), 4 minutes (3-6), and 117 minutes (56-233), respectively. Blood loss was 100 mL (10-300), and the median hospital stay was 5 days (3-12). Postoperative pain scores according to the numerical rating scale (NRS) were 3, 3, and 2 at 1 hour, 24 hours, and 72 hours. Surgeons reported 95/100 median satisfaction. Two minor complications (prolonged air leak, anaemia) resolved conservatively; one readmission for pleural effusion required thoracentesis. No mortality was observed within the 30-day postoperative period.
Conclusions: This study demonstrates the feasibility and acceptable safety of using the SHURUI SP robotic surgery system for anatomical lung resection.
Clinical registration number: The study protocol was registered at http://www.chictr.org.cn/ (ChiCTR2400084046).
Keywords: anatomical lung resection; efficacy; safety; single-port robotic surgery.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.
Conflict of interest statement
Equipment and supplies were provided by SHURUI Co., Ltd. The funder had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.
Figures
Comment in
-
Single-Port Robotics and the Changing Landscape of Thoracic Surgery.Interdiscip Cardiovasc Thorac Surg. 2025 Dec 1;40(12):ivaf292. doi: 10.1093/icvts/ivaf292. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 41344843 Free PMC article. No abstract available.
References
-
- Melfi FM, Menconi GF, Mariani AM, Angeletti CA. Early experience with robotic technology for thoracoscopic surgery. Eur J Cardiothorac Surg. 2002;21:864-868. - PubMed
-
- Chen Y, Zhang C, Wu Z, et al. The SHURUI system: a modular continuum surgical robotic platform for multiport, hybrid-port, and single-port procedures. IEEE/ASME Trans Mechatron. 2022;27:3186-3197.
MeSH terms
LinkOut - more resources
Full Text Sources
